![logo](/logos/NTRB.webp)
Nutriband Inc.
NASDAQ:NTRB
4.43 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Nutriband Inc. |
Symbool | NTRB |
Munteenheid | USD |
Prijs | 4.43 |
Beurswaarde | 49,156,166 |
Dividendpercentage | 0% |
52-weken bereik | 1.53 - 9.595 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Gareth Sheridan |
Website | https://nutriband.com |
An error occurred while fetching data.
Over Nutriband Inc.
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)